NWQ Investment Management Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
NWQ Investment Management Company's BMY Position: Q3 2020 in Review
NWQ Investment Management Company reduced its Bristol-Myers Squibb (BMY) stake by 3.9% in Q3 2020, selling an estimated $2.96M and leaving 1,203,521 shares worth $72.6M. The position accounts for 3.28% of the portfolio, ranked #2.
NWQ Investment Management Company first reported a position in BMY in Q2 2019 and has held it in 6 quarters since. The position peaked at $81.2M in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- NWQ Investment Management Company held 1,203,521 shares of Bristol-Myers Squibb worth $72.6M as of Q3 2020.
- NWQ Investment Management Company sold 49,174 Bristol-Myers Squibb shares in Q3 2020, an estimated $2.96M.
- Bristol-Myers Squibb made up 3.28% of NWQ Investment Management Company's portfolio in Q3 2020, its #2 holding.
- NWQ Investment Management Company first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 6 quarters since.
- NWQ Investment Management Company's Bristol-Myers Squibb position peaked at $81.2M in Q4 2019.
- 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.